For patients with alcohol-related HCC, another concern is that alcohol use was related to sustained expression of proto-onco B-Raf (BRAF), which might result in resistance to sorafenib and other TKIs therapy [27]. The gene discussed is BRAF; the disease is hepatocellular carcinoma.